Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Pain & Musculoskeletal

Effects of photobiomodulation on oral mucositis, oral pain, xerostomia, salivary flow rate, and quality of life in patients with head and neck cancer: a systematic review and meta-analysis

Photobiomodulation appears to be a promising supportive care intervention, reducing the risk of severe mucositis and oral pain, while potentially improving salivary flow rates and preserving quality of life in patients with head and neck cancer.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors systematically reviewed 30 randomized controlled trials with 1748 patients with head and neck cancer to assess photobiomodulation. They report that it was associated with a lower risk of severe oral mucositis and severe oral pain, and higher salivary flow rates, with no significant effect on xerostomia or quality of life. The authors note the evidence certainty was very low to low and most studies had a high risk of bias.

Participants
1,748
Studies included
30
Who or what was studied
Patients with head and neck cancer
Limits stated in the abstract
The certainty of evidence ranged from very low to low and most included studies presented a high risk of bias, so findings should be interpreted with caution.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

Purpose

To systematically review and analyze the effects of photobiomodulation on oral mucositis, xerostomia, salivary flow rates, oral pain, and quality of life in patients with head and neck cancer.

Methods

A systematic search of six databases was conducted up to April 2025. Eligible randomized controlled trials (RCTs) examined the effects of photobiomodulation on the specified outcomes in patients with head and neck cancer. Pooled estimates (risk ratio [RR] and standardized mean difference [SMD]) were calculated using a three-level mixed-effects meta-analysis.

Results

Thirty-three articles describing 30 RCTs (n = 1748) were included. Photobiomodulation significantly reduced the risk of severe oral mucositis (RR 0.46, 95% CI: 0.29-0.71, P < 0.001) and severe oral pain (RR 0.35, 95% CI: 0.23-0.53, P < 0.001) compared with controls. Significant improvements were also observed for salivary flow rate (SMD 0.75, 95% CI: 0.03-1.46, P = 0.044). No significant effects were observed on xerostomia (SMD -0.07, 95% CI: -0.47-0.33, P = 0.646) and quality of life (SMD 1.06, 95% CI: -0.03-2.14, P = 0.060). The benefits were consistent across different photobiomodulation protocols for oral mucositis and quality of life.

Conclusions

Photobiomodulation appears to be a promising supportive care intervention, reducing the risk of severe mucositis and oral pain, while potentially improving salivary flow rates and preserving quality of life in patients with head and neck cancer. However, the certainty of the evidence ranged from very low to low and most included studies presented a high risk of bias; therefore, these findings should be interpreted with caution.

Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.

How to read a review: what to check before relying on this kind of research.

Terms in this paper: Photobiomodulation, Oral mucositis, Meta-analysis, Systematic review, Risk of bias. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies